{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:51:54Z","timestamp":1787161914589,"version":"build-2736575974"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamadermatol.2018.2312","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T16:39:22Z","timestamp":1533141562000},"page":"1145","source":"Crossref","is-referenced-by-count":92,"title":["Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata"],"prefix":"10.1001","volume":"154","author":[{"given":"Solam","family":"Lee","sequence":"first","affiliation":[{"name":"Institute of Hair and Cosmetic Medicine, Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of Hair and Cosmetic Medicine, Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bin","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Hair and Cosmetic Medicine, Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Hair and Cosmetic Medicine, Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi180034r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis.","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi180034r2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2017.10.046","article-title":"Successful treatment of moderate-to-severe alopecia areata improves health-related quality of life.","volume":"78","author":"Liu","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi180034r3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/bjd.14040","article-title":"Diphenylcyclopropenone in patients with alopecia areata: a critically appraised topic.","volume":"173","author":"Kuin","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi180034r4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: an appraisal of new treatment approaches and overview of current therapies.","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi180034r5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/jde.2017.44.issue-11","article-title":"Management of alopecia areata: updates and algorithmic approach.","volume":"44","author":"Lee","year":"2017","journal-title":"J Dermatol"},{"issue":"3","key":"doi180034r6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/archderm.1988.01670030062023","article-title":"Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants.","volume":"124","author":"Wilkerson","year":"1988","journal-title":"Arch Dermatol"},{"issue":"3","key":"doi180034r7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines, part II.","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi180034r8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone.","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"5-6","key":"doi180034r9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.","volume":"299","author":"Wasylyszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"doi180034r10","first-page":"537","article-title":"Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"issue":"1","key":"doi180034r11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF00416931","article-title":"Antigenic competition as a therapeutic concept for alopecia areata.","volume":"267","author":"Happle","year":"1980","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"doi180034r12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000249418","article-title":"Treatment of alopecia areata with diphencyprone.","volume":"171","author":"Orecchia","year":"1985","journal-title":"Dermatologica"},{"issue":"4","key":"doi180034r13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/archderm.133.4.539","article-title":"Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.","volume":"133","author":"Iijima","year":"1997","journal-title":"Arch Dermatol"},{"issue":"3","key":"doi180034r14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaad.2017.10.042","article-title":"Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: retrospective analysis of 159 cases.","volume":"78","author":"Choe","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi180034r15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jaad.2015.04.064","article-title":"Squaric acid sensitization is not required for response in the treatment of alopecia areata.","volume":"73","author":"Vedak","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi180034r16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ajd.1988.29.issue-1","article-title":"Treatment of alopecia areata with diphencyprone.","volume":"29","author":"Hatzis","year":"1988","journal-title":"Australas J Dermatol"},{"issue":"8","key":"doi180034r17","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1111\/jdv.14169","article-title":"Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient.","volume":"31","author":"Choe","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi180034r18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2017.07.028","article-title":"Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: a retrospective study.","volume":"78","author":"Choe","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi180034r19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jdv.2010.24.issue-3","article-title":"Five-year experience in the treatment of alopecia areata with DPC.","volume":"24","author":"El-Zawahry","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"doi180034r20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2017.09.037","article-title":"Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: a retrospective study of 40 patients.","volume":"78","author":"Lee","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi180034r21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjd.1991.125.issue-2","article-title":"Alopecia areata in children: response to treatment with diphencyprone.","volume":"125","author":"Hull","year":"1991","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi180034r22","doi-asserted-by":"publisher","first-page":"35S","DOI":"10.1038\/jid.1995.53","article-title":"Topical immunotherapy in children with alopecia areata.","volume":"104","author":"Orecchia","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"9","key":"doi180034r23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/archdermatol.2012.1622","article-title":"The safety and efficacy of diphencyprone for the treatment of alopecia areata in children.","volume":"148","author":"Salsberg","year":"2012","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi180034r24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2133.1996.tb03835.x","article-title":"Alopecia areata in children: treatment with diphencyprone.","volume":"135","author":"Schuttelaar","year":"1996","journal-title":"Br J Dermatol"},{"key":"doi180034r25","article-title":"Diphencyclopropenone (DPCP) for alopecia areata: a U.K. survey [published online February 26, 2018].","author":"Karanovic","journal-title":"Br J Dermatol"},{"issue":"7","key":"doi180034r26","doi-asserted-by":"crossref","first-page":"13030\/qt224878kb","DOI":"10.5070\/D3237035753","article-title":"Alopecia universalis unresponsive to treatment with tofacitinib: report of a case with a brief review of the literature.","volume":"23","author":"Salman","year":"2017","journal-title":"Dermatol Online J"},{"issue":"6","key":"doi180034r27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1203475417716363","article-title":"A case of topical ruxolitinib treatment failure in alopecia areata.","volume":"21","author":"Deeb","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"doi180034r28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000445182","article-title":"Transient efficacy of tofacitinib in alopecia areata universalis.","volume":"8","author":"Anzengruber","year":"2016","journal-title":"Case Rep Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamadermatology\/fullarticle\/2688586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T12:45:53Z","timestamp":1661690753000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.2312"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.2312","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733755232.793585719","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}